CIK 0001853816 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Dermata Therapeutics, Inc.
Sign in to watch- Ticker
- DRMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (858)-223-0882
- Business address
- 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
- Former names
- Dermata Therapeutics, Inc.
- 4 Grant or award PRESIDENT, CHAIRMAN, CEO acquired 170,068 shares (grant or award)
- 4 Grant or award SVP, CFO acquired 102,040 shares (grant or award)
- 4 Open-market sale Director sold 11 shares at $1.19 ($13)
- 4 Open-market buy SVP, Regulatory Affairs bought 1,000 shares at $1.27 ($1,270)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award SVP, CFO acquired 122,549 shares (grant or award)
- 4 Grant or award PRESIDENT, CHAIRMAN, CEO acquired 612,745 shares (grant or award)
- 4 Grant or award Director acquired 196,851 shares (grant or award)
- 4 Grant or award SVP, CFO acquired 78,741 shares (grant or award)
- 4 Grant or award President, CEO and Chairman acquired 787,402 shares (grant or award)
Page 1 of 6 · 102 filings